Search for: "Generic Pharmaceutical Services, Inc." Results 221 - 240 of 1,028
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jan 2017, 1:28 pm
 Staying with patents, as IPKat member Neil Wilkof discusses on IP Finance the challenges faced by the world’s largest generic drug company, Teva Pharmaceutical Industries Ltd (based in Israel), but whose most successful product in recent years has been the proprietary drug COPAXONE. [read post]
29 Jul 2013, 7:45 am by Schachtman
  In In re Rigel Pharmaceuticals, Inc. [read post]
28 Oct 2017, 2:04 pm by Chuck Cosson
Content Moderation Questions I was privy to a discussion at Google in the spring of 2004 regarding the acceptance of ads from online pharmaceuticals. [read post]
19 Apr 2012, 8:39 am by Matt Osenga
In March, the Supreme Court decided Mayo Collaborative Services, Inc. v. [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
6 Jun 2013, 12:15 am
The doctrine of inherent anticipation (particularly after Schering Co. v Geneva Pharmaceuticals Inc. et Al., commented here - see also, in the UK, Merrell Dow v H N Norton & Co), may lead to similar distortions. [read post]
18 Oct 2011, 9:32 am
Lang, general counsel and global vice president of legal affairs with Whole Foods Market Inc.; Ellen Rosenthal, vice president and assistant general counsel litigation/chief counsel at Pfizer Legal Alliance, Pfizer Inc.; and Erika Rottenberg, vice president, general counsel, and secretary for LinkedIn.Jelich will help provide practical guidance for in-house counsel and law firms seeking to bridge the gap between value and the cost of legal… [read post]
25 Feb 2008, 6:39 pm
As Attorney General, John Ashcroft gained valuable experience testifying before congressional committees. [read post]
6 Sep 2012, 9:17 am by Amber Walsh
Frontier Capital, which focuses exclusively on partnering with the management teams of high growth business services companies, led an investment deal merging a pair of CROs, Inclinix Inc. and PMG Research Inc.. [read post]
10 Mar 2011, 5:00 am by Doug Cornelius
” The complaint focuses on two public companies for which Silverman received non-public information through Guidepoint consultants: Ariad Pharmaceuticals, Inc. and Questcor Pharmaceuticals Inc. [read post]
10 Mar 2011, 5:00 am by Doug Cornelius
The complaint focuses on two public companies for which Silverman received non-public information through Guidepoint consultants: Ariad Pharmaceuticals, Inc. and Questcor Pharmaceuticals Inc. [read post]
5 Jul 2015, 12:59 pm
Among the commercial participants, Genentech Inc. spent the most on general payments (that is, not for research), $387.7 million, mostly royalties for its cancer drugs Rituxan, Avastin and Herceptin to City of Hope National Medical Center in Duarte, Calif., a major cancer center. [read post]